A recent study published in the journal NatureResearchers have published a transcriptome atlas of multiple brain regions in patients with and without Alzheimer's disease (AD). Postmortem...
In a recent review published in the Journal of Neurochemistry, researchers evaluate the impact of the coronavirus disease 2019 (COVID-19) on Alzheimer’s disease (AD) pathology. Study: COVID-19...
In a recent review published in Experimental & Molecular Medicine, researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2). Study: Lipocalin-2: a therapeutic target...
Alzheimer’s disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the...
To commemorate World Parkinson’s Day, we spoke to Michele Hu, Consultant Neurologist at Oxford University Hospitals and Professor of Clinical Neuroscience at the Nuffield Department of Clinical...
Scientists at the Trinity Biomedical Sciences Institute (TBSI) have shed new light on the aging process in the brain. By linking the increased presence of specialized...
Recent Comments